Issue Special Issue 6/2014
Viral Hepatitis and Drug Use in Europe
Content (18 Articles)
Hepatitis – a devastating epidemic in Europe
Jeffrey V Lazarus, Kevin A Fenton
Improved hepatitis C screening and treatment in people who inject drugs should be a priority in Europe
Achim Kautz, Lilyana Chavdarova, Margaret Walker
Ending the mass criminalisation of people who use drugs: a necessary component of the public health response to hepatitis C
Chris Ford, Juliet Bressan
A treatment revolution for those who can afford it? Hepatitis C treatment: new medications, profits and patients
Maria Phelan, Catherine Cook
A national multidisciplinary healthcare network for treatment of hepatitis C in people who inject drugs in Slovenia
Mojca Maticic
The successful implementation of Scotland’s Hepatitis C Action Plan: what can other European stakeholders learn from the experience? A Scottish voluntary sector perspective
Leon Wylie, Sharon Hutchinson, David Liddell, Nicola Rowan
Improving the quality of needle and syringe programmes: an overlooked strategy for preventing hepatitis C among people who inject drugs
Astrid Leicht
Consensus for the integrated management of hepatitis C in Portugal
Ricardo Baptista Leite
A perspective from drug user organisations on ‘ECDC and EMCDDA guidance: prevention and control of infectious diseases among people who inject drugs’
Antonio Corbacho, Manuel Rivera, Francisco Trujillo, Maite Martí, José Carbonell, Francisco Fernández, Alexandre Rosselló, Jordi Perramon, Jaume Salse, Ignacio Ramos
A policy-maker’s perspective on ‘ECDC and EMCDDA guidance: prevention and control of infectious diseases among people who inject drugs’
Joan Colom I Farran
Hepatitis C virus seroprevalence among people who inject drugs and factors associated with infection in eight Russian cities
Robert Heimer, Ksenia Eritsyan, Russell Barbour, Olga S Levina
HIV and hepatitis C co-infection in Europe, Israel and Argentina: a EuroSIDA perspective
Lars Peters, Amanda Mocroft, Jens Lundgren, Daniel Grint, Ole Kirk, Jürgen Kurt Rockstroh
Are there national strategies, plans and guidelines for the treatment of hepatitis C in people who inject drugs? A survey of 33 European countries
Mojca Maticic, Jerneja Videcnik Zorman, Sergeja Gregorcic, Eberhard Schatz, Jeffrey V Lazarus
Policy responses to viral hepatitis B and C among people who inject drugs in Member States of the WHO European region: a sub-analysis of the WHO 2013 global hepatitis policy survey
Alexander Spina, Irina Eramova, Jeffrey V Lazarus
A systematic review of Hepatitis C virus treatment uptake among people who inject drugs in the European Region
Jeffrey V Lazarus, Ida Sperle, Mojca Maticic, Lucas Wiessing
Hepatitis C in European prisons: a call for an evidence-informed response
Amber Arain, Geert Robaeys, Heino Stöver
Roundtable discussion: how lessons learned from HIV can inform the global response to viral hepatitis
Jeffrey V Lazarus, Jens Lundgren, Jordi Casabona, Lucas Wiessing, Catharina Matheï, Peter Vickerman, Maria Prins, Mirjam Kretzschmar, Maria Kantzanou, Isabelle Giraudon, Marica Ferri, Paul Griffiths, Magdalena Harris, Margaret Walker, Lilyana Chavdarova, Eberhard Schatz, Katrin Schiffer, John Peter Kools, Jason Farell, Luís Mendão